A citation-based method for searching scientific literature

Julio Rosenstock, Carol Wysham, Juan P Frías, Shizuka Kaneko, Clare J Lee, Laura Fernández Landó, Huzhang Mao, Xuewei Cui, Chrisanthi A Karanikas, Vivian T Thieu. Lancet 2021
Times Cited: 81



Philip N Newsome, Kristine Buchholtz, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun J Sanyal, Anne-Sophie Sejling, Stephen A Harrison. N Engl J Med 2021
Times Cited: 295




List of shared articles



Times cited

Therapy of Type 2 Diabetes.
Rüdiger Landgraf, Jens Aberle, Andreas L Birkenfeld, Baptist Gallwitz, Monika Kellerer, Harald Klein, Dirk Müller-Wieland, Michael A Nauck, Tobias Wiesner, Erhard Siegel. Exp Clin Endocrinol Diabetes 2022
0

Examining the evidence for weight management in individuals with type 2 diabetes.
W Timothy Garvey, Guillermo E Umpierrez, Julia P Dunn, Anita Y M Kwan, Oralee J Varnado, Manige Konig, Joshua A Levine. Diabetes Obes Metab 2022
0


The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD.
Chandani Patel Chavez, Kenneth Cusi, Sushma Kadiyala. J Clin Endocrinol Metab 2022
12

Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management.
Mohamad B Taha, Tamer Yahya, Priyanka Satish, Rachel Laird, Arthur S Agatston, Miguel Cainzos-Achirica, Kershaw V Patel, Khurram Nasir. Curr Atheroscler Rep 2022
0

Derivatization with fatty acids in peptide and protein drug discovery.
Peter Kurtzhals, Søren Østergaard, Erica Nishimura, Thomas Kjeldsen. Nat Rev Drug Discov 2022
0

Breakthroughs in therapies for NASH and remaining challenges.
Vlad Ratziu, Sven Francque, Arun Sanyal. J Hepatol 2022
1

Glycaemic Control in Diabetes.
D Müller-Wieland, J Brandts, M Verket, N Marx, K Schütt. Handb Exp Pharmacol 2022
0

Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease.
Lucia Brodosi, Francesca Marchignoli, Giulio Marchesini, Maria Letizia Petroni. Expert Opin Pharmacother 2022
0